Billiontoone (NASDAQ:BLLN) Stock: Insider Oguzhan Atay Sells 25,001 Shares

Billiontoone, Inc. (NASDAQ:BLLN) CEO Oguzhan Atay sold 25,001 shares of the company’s stock in a transaction on Monday, November 2nd. The shares were sold at an average price of $109.24, for a total value of $2,731,109.24. Following the transaction, the chief executive officer directly owned 16,667 shares in the company, valued at approximately $1,820,703.08. The trade was a 60.00% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Oguzhan Atay also recently made the following trade(s):

• On Monday, November 2nd, Oguzhan Atay sold 5,334 shares of Billiontoone stock. The shares were sold at an average price of $113.17, for a total value of $603,648.78.
• On Wednesday, October 28th, Oguzhan Atay sold 2,667 shares of Billiontoone stock. The stock was sold at an average price of $118.00, for a total value of $314,706.00.
• On Wednesday, October 28th, Oguzhan Atay sold 8,333 shares of Billiontoone stock. The stock was sold at an average price of $118.00, for a total value of $983,294.00.
• On Thursday, October 15th, Oguzhan Atay sold 5,150 shares of Billiontoone stock. The stock was sold at an average price of $100.23, for a total value of $516,184.50.
• On Wednesday, October 14th, Oguzhan Atay sold 2,667 shares of Billiontoone stock. The shares were sold at an average price of $98.00, for a total transaction of $261,366.00.
• On Wednesday, October 14th, Oguzhan Atay sold 3,183 shares of Billiontoone stock. The shares were sold at an average price of $98.34, for a total transaction of $313,016.22.
• On Monday, October 12th, Oguzhan Atay sold 2,667 shares of Billiontoone stock. The stock was sold at an average price of $97.61, for a total transaction of $260,325.87.
• On Monday, October 12th, Oguzhan Atay sold 16,667 shares of Billiontoone stock. The shares were sold at an average price of $93.79, for a total transaction of $1,563,197.93.
• On Monday, September 28th, Oguzhan Atay sold 2,666 shares of Billiontoone stock. The shares were sold at an average price of $120.64, for a total transaction of $321,626.24.
• On Monday, September 28th, Oguzhan Atay sold 8,333 shares of Billiontoone stock. The stock was sold at an average price of $120.64, for a total value of $1,005,293.12.

Billiontoone Stock Performance

Shares of BLLN traded up $3.44 during trading hours on Wednesday, hitting $113.89. The stock had a trading volume of 582,091 shares, compared to its average volume of 469,134. The company has a debt-to-equity ratio of 0.17, a current ratio of 11.69 and a quick ratio of 11.31. Billiontoone, Inc. has a 12 month low of $61.96 and a 12 month high of $150.44. The firm has a market capitalization of $5.37 billion and a PE ratio of 157.79. The stock has a fifty day moving average price of $104.67 and a 200 day moving average price of $96.89.

Billiontoone (NASDAQ:BLLN) last posted its earnings results on Wednesday, August 5th. The company reported $0.15 earnings per share for the quarter, meeting analysts’ consensus estimates of $0.15. Billiontoone had a return on equity of 9.96% and a net margin of 8.04%. The company had revenue of $109.45 million for the quarter. Analysts anticipate that Billiontoone, Inc. will post 0.80 EPS for the current year.

Key Headlines Impacting Billiontoone

Here are the key news stories impacting Billiontoone this week:

• Positive Sentiment: Q3 results topped expectations: Revenue was about $123.0 million, above the $115.8 million FactSet estimate. Reported earnings per share also exceeded the $0.16 consensus, although sources cite different actual EPS figures ($0.32 and $0.48). BillionToOne Q3 results and guidance
• Positive Sentiment: Higher 2026 revenue guidance: The company raised its full-year revenue outlook, signaling improved expectations for growth. Company announcement
• Negative Sentiment: Multiple insiders sold shares: The CEO, CTO and an SVP reported sales. The transactions were made under pre-arranged Rule 10b5-1 plans, which may temper—but do not eliminate—the bearish signal investors could take from insider selling. Insider transaction reports

Hedge Funds Weigh In On Billiontoone

Several large investors have recently added to or reduced their stakes in the company. Wasatch Advisors LP boosted its position in shares of Billiontoone by 40.2% in the second quarter. Wasatch Advisors LP now owns 518,084 shares of the company’s stock worth $62,160,000 after purchasing an additional 148,446 shares during the period. Renaissance Technologies LLC purchased a new stake in shares of Billiontoone in the first quarter worth $4,046,000. Emerald Advisers LLC raised its position in shares of Billiontoone by 26.8% during the 1st quarter. Emerald Advisers LLC now owns 239,562 shares of the company’s stock valued at $18,911,000 after purchasing an additional 50,613 shares during the period. Public Employees Retirement System of Ohio bought a new stake in shares of Billiontoone during the 1st quarter valued at $1,539,000. Finally, Perceptive Advisors LLC raised its position in shares of Billiontoone by 26.1% during the 1st quarter. Perceptive Advisors LLC now owns 91,812 shares of the company’s stock valued at $7,248,000 after purchasing an additional 19,000 shares during the period.

Analyst Upgrades and Downgrades

BLLN has been the subject of several recent research reports. Weiss Ratings lowered shares of Billiontoone from a “sell (d+)” rating to a “sell (d)” rating in a research report on Thursday, October 8th. Guggenheim upped their target price on shares of Billiontoone from $125.00 to $128.00 and gave the company a “buy” rating in a report on Thursday, October 1st. BTIG Research decreased their price target on shares of Billiontoone from $142.00 to $130.00 and set a “buy” rating on the stock in a research report on Thursday, August 6th. Canaccord Genuity Group started coverage on shares of Billiontoone in a research note on Wednesday, September 2nd. They set a “buy” rating and a $120.00 price target on the stock. Finally, Zacks Research raised shares of Billiontoone from a “strong sell” rating to a “hold” rating in a research report on Friday, October 2nd. Seven analysts have rated the stock with a Buy rating, three have given a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $126.25.

About Billiontoone

BillionToOne, Inc is a molecular diagnostics company that develops tests designed to provide more sensitive and quantitative genetic information from blood samples. The company’s technology is based on its proprietary Quantitative Counting Template (QCT) platform, which is designed to measure DNA molecules with high sensitivity and support the detection of clinically meaningful genetic signals.

The company’s products include prenatal diagnostic and screening solutions marketed under the UNITY brand.